Skip to content

Bidirectional cohort study of primary liver cancer

Bidirectional cohort study of primary liver cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2024000313
Enrollment
Unknown
Registered
2024-08-27
Start date
2024-01-17
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary liver cancer

Interventions

Chinese and western integrative treatment group:Western anti-tumor treatment + traditional Chinese medicine treatment
Chinese medicine treatment group: traditional
Western medicine treatment group:Western anti-tumor treatment

Sponsors

Hubei Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1 The age of first diagnosis is over 18 years old and gender is not limited 2 In line with the above Western diagnostic criteria for primary liver cancer, the stage was ?B-? 3 All the above criteria are met to be included in this study 4 Agree to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1: At the same time, patients with other tumors were primary 2: Did not receive any treatment for liver cancer 3: If the data were incomplete, the key data (patient outcome indicators, syndrome information, etc.) could not be obtained 4: The researcher did not consider it appropriate to include this research 5: Those meeting any of the above criteria were not included in this study

Design outcomes

Primary

MeasureTime frame
Overall survival;

Secondary

MeasureTime frame
Objective response rate (ORR) and disease control rate (DCR);Progression free survival;

Countries

China

Contacts

Public ContactLuoBaoping

Hubei Provincial Hospital of Traditional Chinese Medicine

2392186906@qq.com15907191743

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026